Background. The aim of this study was to test whether early and intensive u
se of continuous venovenous hemofiltration (CVVH) achieved a better than pr
edicted outcome in patients with severe acute renal failure undergoing card
iac operations, and whether a simple and yet accurate model could be develo
ped to predict their outcome before starting CVVH.
Methods. Medical record analysis with collection of demographic, clinical,
and outcome information was used.
Results. Sixty-five consecutive patients were treated with early and intens
ive CVVH (mean operation to CVVH time, 2.38 days; pump-controlled ultrafilt
ration rate, 2 L/h) after coronary artery bypass grafting (56.9%), single v
alve procedure (16.9%), or combined operations (26.2%). In 32.3% of patient
s, intraaortic balloon counterpulsation was required and 20% of patients we
re emergencies. Sustained hypotension despite inotropic and vasopressor sup
port occurred in 40% of patients and prolonged mechanical ventilation in 58
.5%. Using an outcome prediction score specific for acute renal failure, th
e predicted risk of death was 66%. Actual mortality was 40% (p = 0.003). Us
ing multivariate logistic regression analysis and neural network analysis,
patient outcome could be predicted with good levels of accuracy (receiver o
perating characteristic 0.89 and 0.9, respectively).
Conclusions. Early and aggressive CVVH is associated with better than predi
cted survival in severe acute renal failure after cardiac operations. Using
readily available clinical data, the outcome of such patients can be predi
cted before the implementation of CVVH. (C) 2001 by The Society of Thoracic
Surgeons.